Warning: You're using a guest account.
Unless you register as a full user all information associated with this session will be deleted within 24 hours.
Genes associated with Homo sapiens that interact with the MeSH term 'resveratrol' (C059514). Incorporates data from 16 publications curated by the Comparative Toxicogenomics Database (CTD). ODE Gene scores represent number of supporting publications per gene.
QTL associated with castaneus 10 week body weight 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (54321531)
Authors:
Kaput J, Klein KG, Reyes EJ, Kibbe WA, Cooney CA, Jovanovic B, Visek WJ, Wolff GL
QTL associated with femoral cross-sectional area 4. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (61237013)
Authors:
Klein RF, Turner RJ, Skinner LD, Vartanian KA, Serang M, Carlos AS, Shea M, Belknap JK, Orwoll ES
QTL associated with interspecific hybrid testis weight 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (53859617)
Authors:
Elliott RW, Miller DR, Pearsall RS, Hohman C, Zhang Y, Poslinski D, Tabaczynski DA, Chapman VM
QTL associated with postnatal body weight growth 21. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (54321531)
QTL associated with postnatal body weight growth 7. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (54321531)
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
Generated by gene2mesh v. 1.1.1
The developmental history of specific differentiated cell types as traced back to the original STEM CELLS in the embryo.
Generated by gene2mesh v. 1.1.1
The chemical processes, enzymatic activities, and pathways of living things and related temporal, dimensional, qualitative, and quantitative concepts.
Generated by gene2mesh v. 1.1.1
The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.
Generated by gene2mesh v. 1.1.1
Physiology of the human and animal body, male or female, in the processes and characteristics of REPRODUCTION and the URINARY TRACT.
Generated by gene2mesh v. 1.1.1
Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified.
Generated by gene2mesh v. 1.1.1
RNA which does not code for protein but has some enzymatic, structural or regulatory function. Although ribosomal RNA (RNA, RIBOSOMAL) and transfer RNA (RNA, TRANSFER) are also untranslated RNAs they are not included in this scope.
Generated by gene2mesh v. 1.1.1
The series of changes to the shape, size, components, and functions of an individual organism that occur over time as the organism progresses from its initial form to full size and maturity.
Generated by gene2mesh v. 1.1.1
The functions and properties of living organisms, including both the physical and chemical factors and processes, supporting life in single- or multi-cell organisms from their origin through the progression of life.
Generated by gene2mesh v. 1.1.1
RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
Generated by gene2mesh v. 1.1.1
GeneWeaver